Saleha Hafeez

Ms. Saleha Hafeez

Department of Microbiology and Biotechnology, National University of Sciences and Technology, Islamabad, Islāmābād, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Saleha HafeezSaleha Hafeez
Saleha Hafeez
NZNajam Us Sahar Sadaf Zaidi
Najam Us Sahar Sadaf Zaidi
The established blood donation and transfusion system has contributed a lot to human health and welfare, but for this system to function properly, it requires a sufficient number of healthy donors, which is not always possible. Pakistan was a country hit hardest by COVID-19 which additionally reduced the blood donation rates. In order to address such challenges, the present study focused on the development of RBC substitutes that can be transfused to all blood types. This paper reports the development and characterization of RBC substitutes by combining the strategies of conjugated and encapsulated hemoglobin where magnetite nanoparticles would act as the carrier of hemoglobin, and liposomes would separate internal and external environments. The interactions of hemoglobin variants with bare magnetite nanoparticles were studied through molecular docking studies. Moreover, nanoparticles were synthesized, and hemoglobin was purified from blood. These components were then used to make conjugates, and it was observed that only the hemoglobin HbA1 variant was making protein corona. These conjugates were then encapsulated in liposomes to make negatively charged RBC substitutes with a size range of 1–2 μm. Results suggest that these RBC substitutes work potentially in a similar way as natural RBCs work and can be used in the time of emergency.

1 August 2024 in Antibodies
Verified
Journal Article
Open access
PDF file
Saleha HafeezSaleha Hafeez
Saleha Hafeez
NZNajam Us Sahar Sadaf Zaidi
Najam Us Sahar Sadaf Zaidi
Critical blood shortages plague healthcare systems, particularly in lower-income and middle-income countries. This affects patients requiring regular transfusions and creates challenges during emergencies where universal blood is vital. To address these shortages and support blood banks during emergencies, this study reports a method for increasing the compatibility of blood group A red blood cells (RBCs) by blocking surface antigen-A using anti-A single chain fragment variable (scFv). To enhance stability, the scFv was first modified with the addition of interdomain disulfide bonds. The most effective location for this modification was found to be H44-L232 of mutant-1a scFv. ScFv was then produced from E.coli BL21(DE3) and purified using a three-step process. Purified scFvs were then used to block maximum number of antigens-A on RBCs, and it was found that only monomers were functional, while dimers formed through incorrect domain-swapping were non-functional. These antigen-blocked RBCs displayed no clumping in hemagglutination testing with incompatible blood plasma. The dissociation constant KD was found to be 0.724 μM. Antigen-blocked RBCs have the potential to be given to other blood groups during emergencies. This innovative approach could significantly increase the pool of usable blood, potentially saving countless lives.

13 March 2026 in Journal of Biological Engineering
Verified
Journal Article
Open access
PDF file
Saleha HafeezSaleha Hafeez
Saleha Hafeez
Muhammad AsgharMuhammad Asghar
Muhammad Asghar
Background: Access to safe and timely blood transfusion is a cornerstone of modern healthcare but depends on a stable supply of voluntary donations and rigorous hemovigilance systems. O-negative red blood cells are universally compatible and essential for emergency transfusions; however, their scarcity, particularly in low-resource regions, poses significant challenges. To address this challenge, a compact trispecific triabody was designed to block A, B, and Rh(D) antigens on RBCs. Results: In this study, two triabody configurations differing in the placement of the anti-Rh(D) variable domain were generated, producing closed (C1) and open (O1) formats. The selected triabody-C1 was expressed in Escherichia coli BL21(DE3) and purified into two fractions, AE3-B1 and AE3-B2. Hemagglutination assays demonstrated that AE3-B2 did not induce hemagglutination, whereas AE3-B1 showed mixed-field hemagglutination under standard conditions and complete hemagglutination under potentiator-enhanced hemagglutination conditions. ELISA-based binding assays indicated that the triabody’s monomers functioned independently with free antigens, while RBC-bound antigen assays revealed altered binding behavior upon sequential antigen engagement. Blood incompatibility related hemagglutination assays using monoclonal antibodies and incompatible O-negative blood plasma demonstrated complete prevention of hemagglutination by AE3-B2 triabody-coated RBCs, confirming effective antigen blocking. Conclusions: The trispecific triabody efficiently prevents hemagglutination by blocking A, B, and Rh(D) antigens on RBCs, enabling them to exhibit enhanced compatibility and hemagglutinating patterns similar to O-negative cells. These findings provide a promising strategy to increase the pool of compatible blood for transfusion, particularly in emergency and resource-limited settings, while emphasizing that future in vivo investigations are needed to confirm efficacy and safety.

12 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
Saleha HafeezSaleha Hafeez
Saleha Hafeez
MBMuhammad Bhatti
Muhammad Bhatti
MAMuhammad Asghar
Muhammad Asghar
The need for compatible blood remains a persistent challenge to the timely and safe transfusion. Despite this, the stability and functional behavior of antigen-blocking strategies under physiologically relevant conditions remain poorly understood, particularly regarding storage stability, post-exposure behavior, and antigen-specific dissociation in complex biological environments. This study evaluates a trispecific triabody, designed to simultaneously target A, B, and Rh(D) antigens on red blood cells to block antigen recognition and expand donor compatibility. Triabody-coated RBCs were prepared through repeated incubation cycles and assessed for stability in incompatible plasma environments under both storage and physiological conditions. Results showed that the triabody bound efficiently and reached saturation in all tested blood groups. During storage at 4°C, the coating remained stable for over 24 hours with no detectable detachment, hemagglutination or hemolysis. While, under physiological conditions, triabody detached progressively in a pH-dependent manner, with earlier dissociation of anti-B compared to anti-A and anti-Rh(D). This dissociation was followed by hemagglutination in incompatible plasma conditions at 37°C. Triabody-coated RBCs are stable during storage but show differential stability under physiological conditions. These findings support the potential of triabody-coated RBCs to improve transfusion compatibility across different blood types, although further in vivo validation is required before clinical application.

18 December 2025 in Research Square
Verified
Preprint
Open access
PDF file
Saleha HafeezSaleha Hafeez
Saleha Hafeez
Muhammad AsgharMuhammad Asghar
Muhammad Asghar
Background Access to safe and timely blood transfusion is a cornerstone of modern healthcare but depends on a stable supply of voluntary donations and rigorous hemovigilance systems. O-negative red blood cells (RBCs) are universally compatible and essential for emergency transfusions; however, their scarcity, particularly in low-resource regions, poses significant challenges. To help overcome this challenge, a compact trispecific triabody was designed to block A, B, and Rh(D) antigens on RBCs, thereby conferring universal compatibility similar to O-negative RBCs. Results In this study, two combinations based on the placement of the anti-Rh(D) variable chain at the C- or N-terminus were generated, and fusion proteins from the first combination produced the closed (C1) and open (O1) triabodies. Intramolecular cooperative binding affinities of the selected triabody-C1 were predicted computationally using blood group antigens A, B, and Rh(D), with no significant changes observed in binding free energies. The triabody-C1 was expressed in Escherichia coli BL21(DE3) using a two-plasmid system and purified through a three-step process, yielding two fractions, AE3-B1 and AE3-B2. The hemagglutination potential of the triabody was evaluated both visually and microscopically through immunocytochemistry. Visually, no hemagglutination was observed, while microscopically, mixed-field hemagglutination occurred when AB+ and AB − RBCs were incubated with the triabody in fraction AE3-B1, but not when A+ or B+ RBCs were tested. No hemagglutination of AB+ RBCs was detected with the triabody in fraction AE3-B2. ELISA-based cooperative binding assays using free antigens showed that the triabody’s monomers functioned independently, with no changes in binding parameters K D or B max . In contrast, assays with RBC-bound antigens revealed increased K D and decreased B max across successive binding events, particularly when Rh(D) antigens were engaged first. Hemagglutination assays confirmed that triabody-coated RBCs exhibited a complete absence of hemagglutination with anti-A, anti-B, and anti-Rh(D) IgM antibodies, confirming effective antigen blocking. Conclusions The trispecific triabody effectively blocks A, B, and Rh(D) antigens, rendering RBCs with O-negative like universal compatibility and offering a promising strategy to expand the supply of universally transfusable blood, particularly in emergency and resource-limited settings.

31 August 2022 in THE JOURNAL OF MICROBIOLOGY AND MOLECULAR GENETICS
Verified
Journal Article
Open access
PDF file
Saleha HafeezSaleha Hafeez
Saleha Hafeez
SHShahida Hasnain
Shahida Hasnain
It is common practice to drink directly from tops of beverage cans which are exposed to environmental contaminants during handling and storage. The purpose of this research was to determine the bacterial load present on the lids of beverage cans and find out the ways to significantly reduce the number of bacteria present on them. One hundred and eighty apparently clean and non-refrigerated beverage cans were collected from different shops and divided into two groups. First group was used for cleaning experiments and second group was used to determine the effect of refrigeration on bacterial load. Different types of bacteria were isolated which belonged to Bacillus spp, Staphylococcus spp, Corynebacterium spp, Streptococcus spp, Klebsiella spp and Escherichia spp. AST result pattern of S. aureus isolates did not show the presence of MRSA and MSSA. E. coli isolates were found to be highly sensitive to ceftriaxone and highly resistant to erythromycin. Cleaning with tap water plus wiping with dry tissue resulted in maximum removal of bacterial load (76.6%) as compared to other methods (68.8% with dry tissue and 47.3% with tap water) and is thus the most effective method for this purpose. Refrigeration lowered the bacterial load by 16.6%, but it depends upon the type of bacteria present. Beverage cans are present in different environments and are handled by different people and thus can be a potential source of infection for the consumers. It is highly recommended that beverage cans should be cleaned before drinking.